You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Long Acting Injectable Antipsychotic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breakthrough Symptoms With Long-Acting Injectable Medications

Not yet recruiting
  • Schizophrenia
  • Schizophrenia Relapse
  • Second Generation Long-Acting Injectable Antipsychotic Medications
  • (no location specified)
Jul 22, 2022

Schizophrenia Trial in Miami (Aripiprazole Lauroxil, Computerized cognitive and functional skills training)

Not yet recruiting
  • Schizophrenia
  • Aripiprazole Lauroxil
  • Computerized cognitive and functional skills training
  • Miami, Florida
    Jackson Memorial Hospital
Dec 14, 2022

Long-acting Injectable Cabotegravir + Rilpivirine

Not yet recruiting
  • Patient Satisfaction
  • +3 more
    • Santiago, Region Metropolitana, Chile
      CICUC
    Apr 18, 2023

    HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)

    Not yet recruiting
    • HIV-1-infection
    • Once daily CAB tablet + RPV tablet
    • Long acting CAB injectable + long acting RPV injectable
    • Atlanta, Georgia
    • +11 more
    Dec 13, 2022

    Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)

    Recruiting
    • Human Immunodeficiency Virus
    • Opioid Use Disorder
    • Combined LAI Treatment: Cabenuva and Sublocade
    • Providence, Rhode Island
      Rhode Island Hospital
    Aug 7, 2023

    Long-acting Antipsychotics for Mental Ill-Health in Pregnancy

    Not yet recruiting
    • Schizophrenia
    • +7 more
      • Makurdi, Benue State, Nigeria
      • +5 more
      Mar 9, 2023

      HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

      Recruiting
      • HIV Infections
      • Oral Cabotegravir (CAB)
      • +4 more
      • La Jolla, California
      • +30 more
      Feb 2, 2023

      Schizophrenia Trial in Long Beach, Marlton (Lumateperone Long-Acting Injectable)

      Recruiting
      • Schizophrenia
      • Lumateperone Long-Acting Injectable
      • Long Beach, California
      • +1 more
      Apr 7, 2022

      Psychotic Disorders, Schizophrenia, Schizoaffective Disorder Trial in Cleveland (CAE-L)

      Completed
      Has Results
      • Psychotic Disorders
      • +4 more
      • CAE-L
      • Cleveland, Ohio
        University Hospitals Case Medical Center
      Dec 6, 2019

      HIV Reservoir, Inflammation and Microbiota Footprint of PLWH

      Recruiting
      • HIV Infections
      • Stool sampling
      • Blood plasma collection
      • Marseille, France
        Hôpital Européen Marseille
      Jul 26, 2022

      Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)

      Recruiting
      • Human Immunodeficiency Virus
      • +2 more
      • Seattle, Washington
        UW Positve Research, Harborview Medical Center
      May 8, 2023

      HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

      Recruiting
      • HIV-1-infection
      • Kisumu, Kenya
      • +6 more
      Feb 1, 2023

      Preparing for Pharmacy-based Delivery of Long-acting Injectable

      Recruiting
      • Hiv
        • Auburn, Alabama
        • +3 more
        Jun 10, 2022

        Schizophrenia Trial (Brexpiprazole LAI: Dose 1, Brexpiprazole LAI: Dose 2, Brexpiprazole LAI: Dose 3)

        Withdrawn
        • Schizophrenia
        • Brexpiprazole LAI: Dose 1
        • +3 more
        • (no location specified)
        Apr 20, 2022

        Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

        Completed
        • Schizophrenia
        • +4 more
        • Abilify maintena
        • Chungju, Chungcheongbuk-do, Korea, Republic of
        • +26 more
        Dec 16, 2021

        Schizophrenia Trial in United States (Any FDA approved antipsychotic agent, aripiprazole long acting injectable formulation)

        Completed
        Has Results
        • Schizophrenia
        • Any FDA approved antipsychotic agent
        • aripiprazole long acting injectable formulation
        • Tucson, Arizona
        • +38 more
        Nov 16, 2020

        HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

        Not yet recruiting
        • HIV Infections
        • (no location specified)
        Jun 13, 2023

        Schizophrenia Trial (MK-5720, Placebo)

        Not yet recruiting
        • Schizophrenia
        • (no location specified)
        Jul 24, 2023

        HIV Trial in Rio De Janeiro (Cabotegravir Injection)

        Not yet recruiting
        • HIV Infections
        • Cabotegravir Injection
        • Rio De Janeiro, Brazil
          Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
        Aug 23, 2022

        Schizophrenia Trial in Los Angeles (Oral Risperidone, Risperidone in Long-Acting Injectable Form (Consta))

        Completed
        Has Results
        • Schizophrenia
        • Oral Risperidone
        • Risperidone in Long-Acting Injectable Form (Consta)
        • Los Angeles, California
          Semel Institute for Neuroscience and Human Behavior at UCLA
        Mar 8, 2020

        Bunion Trial in Salt Lake City (Local anesthetic injection of CPL-01, Naropin, 0.5% Injectable Solution, Placebo)

        Not yet recruiting
        • Bunion
        • Local anesthetic injection of CPL-01
        • +2 more
        • Salt Lake City, Utah
          Todd Bertoch
        Apr 25, 2023

        Osteoarthritis, Knee Trial in Victoria, London (EP-104IAR, Vehicle)

        Completed
        • Osteoarthritis, Knee
        • Victoria, British Columbia, Canada
        • +2 more
        Aug 30, 2021

        HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)

        Recruiting
        • HIV Infections
        • Standard of Care (SOC) Oral ART
        • +6 more
        • Birmingham, Alabama
        • +34 more
        Dec 1, 2021

        Schizophrenia (Recent-onset) Trial in Los Angeles (paliperidone palmitate, risperidone)

        Completed
        • Schizophrenia (Recent-onset)
        • Los Angeles, California
          UCLA Semel Institute for Neuroscience and Human Behavior
        Apr 7, 2022

        Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable

        Completed
        • Human Immunodeficiency Virus Type 1 (HIV-1)
        • Cabotegravir Injectable Suspension
        • Rilpivirine Injectable Suspension
        • Bakersfield, California
        • +31 more
        May 31, 2023